Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02927262
Brief Title: A Study of ASP2215 (Gilteritinib), Administered as Maintenance Therapy Following Induction/Consolidation Therapy for Subjects With FMS-like Tyrosine Kinase 3 (FLT3/ITD) Acute Myeloid Leukemia (AML) in First Complete Remission

First Submitted : October 5, 2016
First Submitted that Met QC Criteria : October 5, 2016
First Posted : October 7, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : June 2, 2020
Last Update Posted : June 4, 2020